Cited by 66Cardiac electrophysiology and arrhythmiasCardiovascular Function and Risk FactorsCardiomyopathy and Myosin Studies

Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes

Open access
Wahr, Philip A., Michele, Daniel E., Metzger, Joseph M.·1999·Proceedings of the National Academy of Sciences

Abstract

Heart failure frequently involves diastolic dysfunction that is characterized by a prolonged relaxation. This prolonged relaxation is typically the result of a decreased rate of intracellular Ca 2+ sequestration. No effective treatment for this decreased Ca 2+ sequestration rate currently exists. As an approach to possibly correct diastolic dysfunction, we hypothesized that expression of the Ca 2+ binding protein parvalbumin in cardiac myocytes would lead to increased rates of Ca 2+ sequestration and mechanical relaxation. Parvalbumin, which is normally absent in cardiac tissue, is known to act as a soluble relaxing factor in fast skeletal muscle fibers by acting as a delayed Ca 2+ sink. As a test of the hypothesis, gene transfer was used to express parvalbumin in isolated adult cardiac myocytes. We report here that expression of parvalbumin dramatically increases the rate of Ca 2+ sequestration and the relaxation rate in normal cardiac myocytes. Importantly, parvalbumin fully restored the relaxation rate in diseased cardiac myocytes isolated from an animal model of human diastolic dysfunction. These findings indicate that parvalbumin gene transfer offers unique potential as a possible direct treatment for diastolic dysfunction in failing hearts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.96.21.11982

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PV increases the rate of calcium sequestration, lowers presynaptic calcium levels, modulates short-term synaptic plasticity, and prevents cumulative facilitation.

    “PV increases the rate of Ca 2+ sequestration, reduces presynaptic Ca 2+ levels, modulates short-term synaptic plasticity, and prevents cumulative facilitation (Fig. 1), [67,68].”

    From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [68]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [6]Liao R, Helm P A, Hahhar R J, Saha C, Gwathmey J K. Yale J Biol Med. 1995;67:247–264. [PMC free article] [PubMed] [Google Scholar]
  2. [13]Westfall M V, Rust E M, Albayya F, Metzger J M. Methods Cell Biol. 1998;52:307–322. [PubMed] [Google Scholar]
  3. [15]Bers D M. Med Sci Sports Exercise. 1991;23:1157–1162. [PubMed] [Google Scholar]
  4. [19]Masuda H, De Meis L. J Biol Chem. 1977;252:8567–8571. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Wahr, P. A., Michele, D. E., & Metzger, J. M.
Affiliations
University of Michigan (US)
Venue
Proceedings of the National Academy of Sciences
Published
1999-10-12
Volume
96
Issue
21
Pages
11982-11985
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2065503803
Cited by
66
References
22
Citations by year
2024: 1 · 2022: 2 · 2020: 3 · 2019: 1 · 2014: 1 · 2013: 3 · 2012: 5
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
parvalbumin, diastolic dysfunction, heart failure, calcium sequestration, cardiomyocytes, gene transfer, calcium-binding proteins, mechanical relaxation, cardiac gene therapy
MeSH terms
Animals, Calcium, Cells, Cultured, Diastole, Disease Models, Animal, Female, Heart Failure, Hypothyroidism, Myocardium, Parvalbumins, Sarcomeres, Time Factors, Blotting, Western, Rats, Sprague-Dawley, Gene Transfer Techniques, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review